Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001437749-26-019479
Filing Date
2026-06-04
Accepted
2026-06-04 08:50:21
Documents
3
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K athe20260604_6k.htm 6-K 10657
2 EXHIBIT 99.1 ex_972197.htm EX-99.1 9184
3 logo.jpg GRAPHIC 6803
  Complete submission text file 0001437749-26-019479.txt   30521
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE Australia
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE Australia 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 261063328
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)